Find, compare & contact
Carbonate ion API Manufacturers & Suppliers

teaser-1024x654-1
Contact suppliers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Carbonate ion is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Carbonate ion or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Carbonate ion API 3812-32-6?

Description:
Here you will find a list of producers, manufacturers and distributors of Carbonate ion. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Carbonate ion 
Synonyms:
Carbonate  
Cas Number:
3812-32-6 
DrugBank number:
DB14531 
Unique Ingredient Identifier:
7UJQ5OPE7D

General Description:

Carbonate ion is a chemical compound identified by the CAS number 3812-32-6. It is known for its distinct pharmacological properties and applications.

Categories:

Carbonate ion is categorized under the following therapeutic classes: Alkalies, Anions, Carbon Compounds, Inorganic, Carbonic Acid, Electrolytes, Ions. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.

Carbonate ion is a type of Alkalinizing agents


Alkalinizing agents, a pharmaceutical API category, refers to a group of substances used to increase the pH (alkalinity) of a solution or body fluid. These agents play a crucial role in various medical applications, such as the treatment of acidosis, kidney disorders, and certain drug overdoses.

One commonly used alkalinizing agent is sodium bicarbonate, which is highly effective in raising the pH of blood and urine. It works by neutralizing excess acid and restoring the acid-base balance in the body. Sodium bicarbonate is often administered intravenously in emergency situations to rapidly correct severe acidosis.

Another alkalinizing agent, acetazolamide, is frequently employed in the treatment of glaucoma and certain types of epilepsy. By inhibiting carbonic anhydrase, acetazolamide reduces the production of bicarbonate ions, leading to a systemic decrease in pH. This mechanism is particularly useful in lowering the intraocular pressure associated with glaucoma.

Alkalinizing agents are also utilized in the management of certain drug toxicities. For instance, methotrexate, a chemotherapy medication, can cause severe toxicity if its elimination is hindered. Alkalinizing the urine with agents like sodium bicarbonate enhances methotrexate solubility, preventing the formation of toxic crystals in the kidneys.

In conclusion, alkalinizing agents are indispensable pharmaceutical APIs that help correct acid-base imbalances, treat specific medical conditions, and mitigate drug toxicities. Their diverse applications make them valuable tools in modern medicine.